Webinar presenters Wei Zhang, MD, PhD, Medical Director of Molecular Pathology (Solid Tumor), University of Kansas, and Tejas Patil, MD, Thoracic Medical Oncologist, UCHealth, University of Colorado, discuss RNA testing practices and pathogenic gene fusions testing, with special focus on NRG1 fusions testing and management.
This on-demand webinar was originally broadcast on November 5, 2025.
What will you learn from this webinar?
• Understand the clinical utility of NRG1 fusions as a poor prognostic factor across tumor types, exploring NRG1+ tumors’ metastatic potential and histological features.
• Learn RNA testing best practices and explore the interaction between pathologists and oncologists on NRG1+ testing and management.
• Ask questions of our distinguished presenters.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.